Please join us for an ECHO webinar featuring Garrett Schwab, who will provide an overview of his vast experience developing and commercializing novel therapeutic medical technologies.
XII Medical is a privately held medical technology company developing a novel neurostimulation system designed to improve patient experience and outcomes for the millions suffering from Obstructive Sleep Apnea.
Garrett Schwab, BA, MBA
President and CEO, XII Medical
ECHO is an entrepreneurship training program, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP), the University of Toronto component of the Ted Rogers Centre for Heart Research, and (ii) the Health Innovation Hub (H2i). For more information, visit: https://tedrogersresearch.ca/echo/